
Prelude Therapeutics Inc
PRLDNasdaqCIK 1678660HealthcareFiscal year ends Dec 31
Reports and events: 115 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-02-1516:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-015913 |
| 2023-12-1316:55 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-125744 |
| 2023-12-1109:17 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-069210 |
| 2023-11-0116:37 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-057523 |
| 2023-11-0116:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-057481 |
| 2023-08-0308:14 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-037611 |
| 2023-08-0308:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-202314 |
| 2023-06-2116:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-171145 |
| 2023-06-0116:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-025712 |
| 2023-05-2416:47 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-23-000625 |
| 2023-05-2416:31 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-064148 |
| 2023-05-1916:06 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-149304 |
| 2023-05-1716:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-146980 |
| 2023-05-0808:11 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-018478 |
| 2023-05-0808:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-018477 |
| 2023-04-2808:46 ET | DEF 14A | Proxy statementPeriod 2023-06-16 | 0000950170-23-015497 |
| 2023-03-1516:38 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-23-071400 |
| 2023-03-1508:53 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-007989 |
| 2023-03-1508:31 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-007983 |
| 2023-02-1411:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-002729 |
| 2023-01-2316:16 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-23-001023 |
| 2023-01-0908:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-000439 |
| 2022-11-1408:27 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-024732 |
| 2022-11-1408:21 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-024727 |
| 2022-08-0908:12 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001564590-22-028596 |
| 2022-08-0908:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-22-028595 |
| 2022-06-2108:00 ET | 8-K | 5.07 Shareholder vote results | 0001564590-22-023674 |
| 2022-05-1008:11 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001564590-22-019085 |
| 2022-05-1008:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-22-019084 |
| 2022-04-2907:59 ET | DEF 14A | Proxy statementPeriod 2022-06-17 | 0001564590-22-016626 |
| 2022-04-0816:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-100388 |
| 2022-03-1708:11 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001564590-22-010723 |
| 2022-03-1608:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-22-010534 |
| 2022-03-0908:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-070007 |
| 2022-02-1617:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-044450 |
| 2022-01-1007:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-005032 |
| 2021-12-0309:00 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-21-347333 |
| 2021-11-1208:28 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001564590-21-056509 |
| 2021-11-1207:57 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-056478 |
| 2021-09-1708:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-275680 |
| 2021-08-1210:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-043724 |
| 2021-08-1210:36 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-043718 |
| 2021-07-1916:53 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-218690 |
| 2021-06-2216:02 ET | 8-K | 5.07 Shareholder vote results | 0001193125-21-196185 |
| 2021-05-1209:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-158457 |
| 2021-05-1108:15 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-026308 |
| 2021-05-1108:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-026296 |
| 2021-04-2916:05 ET | DEF 14A | Proxy statementPeriod 2021-06-18 | 0001193125-21-140361 |
| 2021-03-1709:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-083591 |
| 2021-03-1608:20 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-013330 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.